Episode 3: Targeting the Undruggable

In this episode, we speak with Gary O'Neill, Chief Scientific Officer at Belharra, about our next-generation chemoproteomics platform, which has the potential to open up the entire proteome – for the first time – to small molecule screening which could lead to many undruggable proteins becoming druggable. Most importantly, we talk about the immense positive impact we believe this science and our platform could have for individuals and for society as we strive to create medicines for currently intractable diseases.